About Gleamer SAS
Gleamer SAS is a French medtech company that has pioneered the development of artificial intelligence (AI) solutions designed to significantly enhance diagnostic capabilities and workflow efficiency within radiology. Founded in 2017, Gleamer’s core offering, the Gleamer Copilot platform, provides radiologists and clinicians with a sophisticated concurrent reading aid. This platform leverages deep learning algorithms to perform semi-automated pre-diagnosis of medical images, facilitating the detection of various pathologies and the generation of structured, reliable reports. The overarching mission is to improve the quality of patient care by increasing diagnostic accuracy and reducing the substantial workload faced by radiologists globally.
The company’s comprehensive portfolio includes a range of FDA-cleared and CE-marked solutions across multiple imaging modalities, including X-ray, CT, and MRI. Key products address critical areas such as musculoskeletal imaging with BoneView for bone trauma detection, BoneAge for automated pediatric bone age assessment, and BoneMetrics for precise musculoskeletal measurements. Additionally, Gleamer offers ChestView for identifying thoracic pathologies on chest X-rays, and has expanded into breast imaging with BreastView (for mammography) and neurological applications with solutions like Pixyl.Neuro.MS for MRI interpretation. These AI tools are engineered to act as a safety net, catching subtle findings that might otherwise be missed, thereby improving radiologists’ sensitivity and accuracy across a broad spectrum of conditions, from fractures and lung nodules to mammography pathologies and brain MRI findings.
By seamlessly integrating into existing hospital workflows, Gleamer’s solutions aim to streamline operations, reduce repetitive tasks, and accelerate turnaround times. This allows radiologists to dedicate more focus to complex cases and higher-value clinical decisions, ultimately leading to improved efficiency and better patient outcomes. The company’s commitment to clinically validated AI is demonstrated by its numerous publications and widespread adoption in over 700 customer contracts across 44 countries.
Focus Areas
Business Intelligence
| Key Investors | Supernova Invest, Heal Capital, XAnge, Elaia, Bpifrance, MACSF, Crista Galli Ventures, UI Investissement, several European radiologists |
| Partnerships | France Imageries Territoires (FIT), Aidoc, Konica Minolta Healthcare, Siemens Healthineers, Fujifilm, Ferrum Health, RMS Medical Devices, VIDI, Wellbeing Software, DATAMED, Philips, Sectra, Blackford |
| Acquisitions | Pixyl, Caerus Medical (acquired by Gleamer); Acquired by RadNet (DeepHealth) |
| Technology | Cloud-native, AI-powered platform, deep learning algorithms, Gleamer Copilot®, Detectron2 architecture |
| FDA Clearances | 4 cleared products (estimated) |
What Physicians Need to Know
For physicians, Gleamer's AI solutions act as a reliable 'safety net,' designed to catch findings that might be missed, particularly in high-volume or emergency settings, or during night shifts. The clinically validated algorithms significantly improve diagnostic accuracy and sensitivity across modalities, leading to greater confidence in diagnoses. Expect substantial time savings through automated measurements, pre-filled reports, and reduced repetitive tasks, allowing more focus on complex clinical decisions and patient interaction. The unified platform (Gleamer Copilot) ensures a consistent and intuitive experience, making it easy to integrate new AI tools into your daily workflow. This ultimately translates to improved patient care through quicker and more precise diagnoses, and a reduction in radiologist workload.
Gleamer's solutions, including the Gleamer Copilot and GleamerOS, are built for seamless integration into existing hospital infrastructure, including PACS/RIS systems. They utilize a single gateway for orchestrating all solutions and modalities, simplifying deployment for IT teams. The cloud-native architecture, powered by Google Cloud, ensures scalability, performance, security (HIPAA, GDPR, HDS certified), and compliance, with patient data pseudonymization. The platform supports advanced workflows like automated exam prioritization and longitudinal follow-up, connecting prior and present exams for a continuous patient health view.
What the Web Says
Gleamer SAS is a French company specializing in AI-powered medical imaging software, aiming to enhance diagnostic accuracy and efficiency for healthcare professionals. Their products, such as BoneView and ChestView, assist in detecting various conditions like bone fractures, lung nodules, pneumothorax, and pleural effusion across different imaging modalities. The company has received FDA clearance for several of its tools and has expanded its operations globally since its establishment in 2016. In March 2026, RadNet acquired Gleamer SAS, integrating it into its DeepHealth subsidiary to become a major provider of radiology clinical AI solutions worldwide.
Overall: PositiveStrengths
- Improved diagnostic accuracy and speed.
- Supports multiple imaging modalities (X-rays, MRIs, CT scans, mammograms).
- Intuitive interface and ease of use.
- Seamless integration with existing medical imaging systems (PACS, EMR, RIS).
- Reduces human error and assists in detecting subtle anomalies.
- Offers reporting automation and detailed diagnostic reports.
Limitations
- Specific pricing details are not publicly available, and it can be expensive.
- Some Reddit users report false positives and over-calling by AI, leading to extra work for radiologists.
- AI may miss some clinically significant findings.
- Potential for AI to introduce bias if used before a radiologist's initial read.
- Limited features in some versions or a need for additional features (e.g., attrition ratio calculations for HR software, though this may refer to a different 'GleamHR' product).
- Concerns about the accuracy of reviews on platforms like Capterra due to incentivized or potentially fake reviews.
Based on reviews from: Gleamer (gleamer.ai), SoftwareWorld, ITQlick, BioWorld, Reddit (r/Radiology, r/StockTitan), Fierce Biotech, Indeed.com (for 'The Gleamery' and 'GLE Associates, Inc.' - note: these may not be Gleamer SAS), Capterra (for 'Gleam Apps Software' and 'GleamHR Software' - note: these may not be Gleamer SAS), G2 (for 'Glew' and 'GleamHR' - note: these may not be Gleamer SAS), PMC (PubMed Central)
Last updated: 2026-07-18
Videos
News, demos, and interviews about Gleamer SAS.
Videos load interactively. If none appear, search YouTube for Gleamer SAS →
Press & Coverage
Frequently Asked Questions
Comparisons
Related Companies
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]
MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]
allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]